Eurofins Scientific Shares Rebound to €60.58 After Holding Key Support
Eurofins Scientific regains momentum during the session, reaching €60.58, in a Paris market trending sharply upwards. The CAC 40 is up 2.95% at midday, amid easing geopolitical tensions in the Middle East. The bioanalytical testing specialist's stock is attempting to stabilize its trajectory after a disappointing quarterly report in April.
Technical Rebound on Low Zone Indicators
Eurofins Scientific's stock advances 3.13% to €60.58, after slipping below €58 on Monday. However, the stock remains distant from its 50-day and 200-day moving averages, both around €64, maintaining a medium-term downward trend. The RSI at 36 indicates seller fatigue over the past weeks, without yet entering a characterized oversold zone. The price is moving in the lower part of the Bollinger Bands, close to the lower boundary at €55.54. The support identified at €57.54 held during the last two sessions, paving the way for the observed rebound during the day. Over three months, the decline reaches 11.51%.
Busy Schedule Following a Disappointing Quarterly Publication
Today's movement occurs without any identified catalyst in the group's news. To recall, the first quarter publication on April 22 caused the stock to drop more than 10% in one session, with organic growth limited to 2.5%, hindered by weather conditions in Europe and North America. The group then maintained its organic growth targets for the fiscal year 2026. Several strategic operations mark the semester. The divestiture of the MET Labs division to UL Solutions, valued at €575 million, is part of the focus on life testing. Concurrently, a seventh share buyback program, covering 4.5% of the capital, was launched at the end of April. Upcoming key dates in the financial calendar include the general assembly on May 27, followed by the semi-annual results on September 18.
